Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(38%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
25%
Ph phase_2
1
13%
Ph phase_1
1
13%
Ph phase_3
2
25%
Ph phase_4
2
25%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(6)
Completed(2)

Detailed Status

Recruiting3
Not yet recruiting3
Completed2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (12.5%)
Phase 21 (12.5%)
Phase 32 (25.0%)
Phase 42 (25.0%)
N/A2 (25.0%)

Trials by Status

recruiting338%
completed225%
not_yet_recruiting338%

Recent Activity

3 active trials
Showing 5 of 8
not_yet_recruitingphase_4

Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study

NCT07572032
recruitingnot_applicable

Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy

NCT07491718
recruitingphase_1

Vericiguat in Decompensated Cardiac Failure: Clinical Insights on Addition to Guidelines Derived Medical Therapy-VERCIG Trial

NCT07444398
not_yet_recruitingphase_4

The Effect of Sacubitril and Valsartan on Heart Function in Chronic Hemodialysis Patients With HFpEF

NCT07417215
completedphase_2

Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure

NCT07023016
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07572032Phase 4

Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study

Not Yet Recruiting
NCT07491718Not Applicable

Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy

Recruiting
NCT07444398Phase 1

Vericiguat in Decompensated Cardiac Failure: Clinical Insights on Addition to Guidelines Derived Medical Therapy-VERCIG Trial

Recruiting
NCT07417215Phase 4

The Effect of Sacubitril and Valsartan on Heart Function in Chronic Hemodialysis Patients With HFpEF

Not Yet Recruiting
NCT07023016Phase 2

Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure

Completed
NCT06712030Phase 3

Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection Fraction

Not Yet Recruiting
NCT05508035Phase 3

The Effect of Sacubitril/valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients with Ischemic Heart Failure with Mid-range Ejection Fraction

Recruiting
NCT04587947Not Applicable

Influence of Sacubitril/Valsartan on Autonomic Cardiac Nervous System in Heart Failure Patients: an Exploratory Study

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8